ProSense® Lung Cryoablation
Stage I non‑small cell lung cancer (T1N0M0)
CE‑marked, clinical registryActive
Key Facts
Indication
Stage I non‑small cell lung cancer (T1N0M0)
Phase
CE‑marked, clinical registry
Status
Active
Company
About IceCure Medical
IceCure provides a liquid‑nitrogen cryoablation platform for minimally invasive tumor destruction across multiple oncology indications.
View full company profile